Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Sanofi transfers Hyalgan rights back to Fidia Farmaceutici

Sep. 20, 2011

Merck KGaA acquires exclusive worldwide rights to experimental MS treatment

Sep. 19, 2011

Eisai enters collaboration with SFJ to conduct phase III E-7080 trials

Sep. 15, 2011

Oncothyreon obtains license to anticancer agents from Sanford-Burnham Medical Research Institute

Sep. 15, 2011

Ampio and Daewoong enter urology drug agreement in South Korea

Sep. 15, 2011

Ono Pharmaceutical enters agreement with Servier for ivabradine

Sep. 14, 2011

Seattle Genetics and Oxford BioTherapeutics form antibody-drug conjugate collaboration

Sep. 14, 2011

Hawthorn Pharmaceuticals and CoPlex Therapeutics enter licensing deal

Sep. 14, 2011

Juvaris and Colby Pharmaceutical enter agreement for CLDC technology and JVRS-100

Sep. 14, 2011

Merck & Co. and BGI join to discover and develop biomarkers and genomic technologies

Sep. 13, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...